Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1417835Generated: October 26, 2026

Trimethylsilyl isocyanate → 1-(4-Methoxyphenyl)-4-[2-(5-aminocarbonylisochroman-1-yl)ethyl]piperazine

https://huagongshe.com/reaction/1417835

Reaction equation

Participants

RoleNameHCIDCharge
ReactantTrimethylsilyl isocyanateHCID 70696—
Reactant1-(4-Methoxyphenyl)-4-[2-(5-bromoisochroman-1-yl)ethyl]piperazineHCID 23288744—
ReactantHCID 178418306HCID 178418306—
SolventTetrahydrofuranHCID 8028—
Solvent1,4-DioxaneHCID 31275—
Product1-(4-Methoxyphenyl)-4-[2-(5-aminocarbonylisochroman-1-yl)ethyl]piperazineHCID 23288829—

Reaction Steps

A mixture of t-butyl lithium (2 eqs, 1.7M in hexane) in THF (2 ml/mmol bromide) is cooled to -78° for 10 minutes before adding the 1-(4-methoxyphenyl)-4-[2-(5-bromoisochroman-1-yl)ethyl]piperazine (LXXIV, EXAMPLE 100) in THF (4 ml/mmol) dropwise over 10 minutes. A freshly distilled solution of trimethylsilylisocyanate (1.5 eqs) is added via syringe as a solution in dioxane (4 volume equivalents) at once. After 15 minutes, the cooling bath is removed and the mixture allowed to warm to 20°-25°. The reaction mixture is quenched with ammonium chloride, the organics are removed under reduced pressure, and the aqueous residue is extracted two times with methylene chloride, dried over sodium sulfate, filtered and concentrated. The crude material is purified by flash chromatography on silica gel. In this manner, 1-(4-methoxyphenyl)-4-[2-(5-bromoisochroman-1-yl)ethyl]piperazine (LXXIV, EXAMPLE 100, 345 mg) is converted to the corresponding amide, the title compound, mp 185°-186°.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS05877317
Source datasetuspto-grants-1999_03
ORD IDord-d878029febda4befa871bebf18ae3d89
Source noteuspto-grants-1999_03